(Q86309140)
Statements
Earlier sustained virologic response end points for regulatory approval and dose selection of hepatitis C therapies (English)
Jianmeng Chen
Jeffry Florian
Wendy Carter
Russell D Fleischer
Thomas S Hammerstrom
Pravin R Jadhav
Wen Zeng
Jeffrey Murray
Debra Birnkrant